Acceptance and side effects of COVID-19 vaccination among private dental practitioners and their staffs in Belagavi city
Keywords:
dentist, COVID-19, vaccination, dental staffs, covaxin, covishieldAbstract
Background: In January 2021, India launched its largest COVID-19 vaccination campaign. Vaccines were distributed at 3,006 locations across India. The health-care workers were given first preference for vaccination. Vaccines are intended to provide immunity without the risk of disease transmission. Methods: A survey was conducted among private dental practitioners and their staff to inquire about their vaccination status, symptoms experienced, post-vaccination dental practice, and out-patient care. A complete list of registered dentists was compiled. A total of 315 participants were interviewed, including both private dental practitioners and their staffs, and data collected via phone call. Results: A total of 315 participants from 120 Dental Clinics in Belgaum City were included in the current study. 84.1% of the population were immunized. The majority of them (80.38%) were vaccinated with Covishield, and (69.06%) received two doses. In addition, 90.57% of participants experienced one or more symptoms following vaccination. The main symptoms reported were Fever/Chills (50.19%), Fatigue (27.12%), Headache (22.26%). Only 0.75% had diarrhea. None of the symptoms were life-threatening or necessitated hospitalization. Conclusion: The vaccine acceptance rate was 84.1% in the study. Mild and short post-vaccination symptoms was reported in more than two-thirds of healthcare professionals.
Downloads
References
The Hindu: Coronavirus updates, July 18, 2021.
World Health Organisation: India rolls out the world’s largest COVID-19 vaccination drive [Internet]. Jan 2021. Available from: https://www.who.int/india/news/feature- stories/detail/india-rolls-out
World Health Organisation: Side effects of COVID-19 vaccines. [Internet] 2021. DOI: https://doi.org/10.4324/9781003120254-3
Indiatoday: Covid-19 vaccines in India: Prices and doses to availability, complete guide. Jul 2021.
Baghizadeh Fini M. What dentists need to know about COVID-19. Oral Oncol. 2020 Jun;105:104741. DOI: https://doi.org/10.1016/j.oraloncology.2020.104741
Bhanushali P. “COVID-19: Changing trends and its impact on future of Dentistry”. International Journal of Dentistry, 2020. DOI: https://doi.org/10.1155/2020/8817424
Jayadevan, Rajeev & Shenoy, Ramesh & T S, Anithadevi. (2021). Survey of symptoms following COVID-19 vaccination in India. 10.1101/2021.02.08.21251366. DOI: https://doi.org/10.1101/2021.02.08.21251366
L. Bunch, “A tale of two crises: addressing Covid-19 vaccine hesitancy as promoting racial justice,” Hec Forum, pp. 1–12, 2021. DOI: https://doi.org/10.1007/s10730-021-09440-0
Di Giuseppe G, Nobile CGA,Marinelli P, Angelillo IF. A survey of knowledge,
attitudes, and behavior of Italian dentists toward immunization. Vaccine. (2007) 25:1669–75. DOI: https://doi.org/10.1016/j.vaccine.2006.10.056
La Vecchia C., Negri E., Alicandro G., Scarpino V. Attitudes towards influenza vaccine and a potential COVID-19 vaccine in Italy and differences across occupational groups, September 2020. Med Lav. 2020; 17 (111(6): 445-448)
Lazarus J.V.,Ratzan S.C., Palayew A. et al. A global survey of potential acceptance of a COVID-19 vaccine. Nat Med. 2021; 27: 225-228 DOI: https://doi.org/10.1038/s41591-020-1124-9
Hornsey, M. J., Finlayson, M., Chatwood, G. & Begeny, C. T. Donald Trump and vaccination: the effect of political identity, conspiracist ideation and presidential tweets on vaccine hesitancy. J. Exp. Soc. Psychol. 88,103947 DOI: https://doi.org/10.1016/j.jesp.2019.103947
Bokemper, S. E., Huber, G. A., Gerber, A. S., James, E. K. & Omer, S. B. Timing of COVID-19 vaccine approval and endorsement by public figures. Vaccine 39, 825–829 DOI: https://doi.org/10.1016/j.vaccine.2020.12.048
SJ Polack FP, Thomas, Kitchin N et al. Safety and efficacy of the BNT162b2 mRNA COVID-19 vaccine. N Engl J Med. 2020; 383: 2603-2615 DOI: https://doi.org/10.1056/NEJMoa2034577
Published
How to Cite
Issue
Section
Copyright (c) 2022 International journal of health sciences
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Articles published in the International Journal of Health Sciences (IJHS) are available under Creative Commons Attribution Non-Commercial No Derivatives Licence (CC BY-NC-ND 4.0). Authors retain copyright in their work and grant IJHS right of first publication under CC BY-NC-ND 4.0. Users have the right to read, download, copy, distribute, print, search, or link to the full texts of articles in this journal, and to use them for any other lawful purpose.
Articles published in IJHS can be copied, communicated and shared in their published form for non-commercial purposes provided full attribution is given to the author and the journal. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
This copyright notice applies to articles published in IJHS volumes 4 onwards. Please read about the copyright notices for previous volumes under Journal History.
